Silvaco Group, Inc.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
SVCO$7.03+4.5%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(28,682) | $(37,010) |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 1,146 | 475 |
| Stock-based compensation expense | 4,397 | 21,829 |
| Provision for credit losses | 116 | 143 |
| Litigation settlement | 13,069 | 14,696 |
| Loss on debt extinguishment | — | 718 |
| Accretion of discount on marketable securities, net | (462) | (194) |
| Change in fair value of contingent consideration | 52 | (18) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 97 | (3,102) |
| Contract assets | 4,832 | (4,081) |
| Prepaid expenses and other current assets | (1,073) | (882) |
| Other assets | 32 | (84) |
| Accounts payable | (1,576) | (2) |
| Accrued expenses and other current liabilities | (16,586) | (1,287) |
| Related party funding of litigation apportionment agreement | 6,000 | — |
| Accrued income taxes | (714) | 687 |
| Deferred revenue | 2,719 | (673) |
| Other non-current liabilities | 20 | (9) |
| Net cash used in operating activities | (16,613) | (8,794) |
| Cash flows from investing activities: | ||
| Sales of marketable securities | 10,345 | — |
| Purchases of marketable securities | — | (67,809) |
| Maturities of marketable securities | 32,000 | — |
| Acquisition of businesses | (14,306) | — |
| Purchases of property and equipment | (222) | (56) |
| Net cash provided by (used in) investing activities | 27,817 | (67,865) |
| Cash flows from financing activities: | ||
| Proceeds from initial public offering, net of underwriting fees | — | 106,020 |
| Proceeds from issuance of convertible note, net of debt issuance costs | — | 4,852 |
| Proceeds from loan facility | — | 4,250 |
| Repayment of loan facility | — | (4,250) |
| Repayment of related party line of credit | — | (2,000) |
| Deferred transaction costs | — | (2,126) |
| Proceeds from issuance of common stock for share-based awards | 361 | — |
| Payment of payroll taxes related to shares withheld from employees | (586) | — |
| Contingent consideration | (46) | (22) |
| Payments of vendor financing obligation | (1,328) | (300) |
| Net cash (used in) provided by financing activities | (1,599) | 106,424 |
| Effect of exchange rate fluctuations on cash and cash equivalents and restricted cash | 421 | 88 |
| Net increase in cash and cash equivalents and restricted cash | 10,026 | 29,853 |
| Cash and cash equivalents and restricted cash, beginning of period | 19,606 | 4,421 |
| Cash and cash equivalents and restricted cash, end of period | $29,632 | $34,274 |
| Cash and cash equivalents and restricted cash: | ||
| Cash and cash equivalents | 13,132 | 34,274 |
| Restricted cash | 16,500 | — |
| Total cash and cash equivalents and restricted cash | $29,632 | $34,274 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.